Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability

Blood

Volumn 95, Issue 6, 2000, Pages 1891-1899

  Carballo, Ester ^b   Lai, Wi S ^b   Blackshear, Perry J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; TRISTETRAPOLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA METABOLISM;

EID: 0034653560     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.6.1891     Document Type: Article

References (51)

1. Varnum BC, Lim RW, Sukhatme VP, Herschman HR. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene. 1989;4:119.
2. Lai WS, Stumpo DJ, Blackshear PJ. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem. 1990;265: 16,556.
3. DuBois RN, McLane NW, Ryder K, Lau LF, Nathans DA. Growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem. 1990;265:19,185.
4. Taylor GA, Lai WS, Oakey RJ, et al. The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res. 1991;19:3454.
5. Varnum BC, Ma Q, Chi T, Fletcher B, Herschman HR. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol Cell Biol. 1991; 11:1754.
6. 1 switch gene homologous to a rodent gene encoding a zinc-binding potential transcription factor. DNA Cell Biol. 1993;12:73.
7. Thompson MJ, Lai WS, Taylor GA, Blackshear PJ. Cloning and characterization of two yeast genes encoding members of the CCCH class of zinc finger proteins: zinc finger-mediated impairment of cell growth. Gene. 1996;174:225.
8. De J, Lai WS, Thorn JM, et al. Identification of four CCCH zinc finger proteins in Xenopus, including a novel vertebrate protein with four zinc fingers and severely restricted expression. Gene. 1999;228:133.
9. Taylor GA, Thompson MJ, Lai WS, Blackshear PJ. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen activated protein kinase in vitro. J Biol Chem. 1995; 270:13,341.
10. Taylor GA, Thompson MJ, Lai WS, Blackshear PJ. Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor. Mol Endocrinol. 1996;10:140.
11. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science. 1998;281: 1001.
12. Taylor GA, Carballo E, Lee DM, et al. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 1996;4:445.
13. Carballo E, Gilkeson GS, Blackshear PJ. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. J Clin Invest. 1997; 100:986.
14. Shyu A-B, Greenberg ME, Belasco JG. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 1989;3:60.
15. Xu N, Chen C-YA, Shyu A-B. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay, Mol Cell Biol. 1997;17:4611.
16. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol. 1999; 19:4311.
17. Rothe J, Lessiauer W. Lötscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993;364:798.
18. Erickson SL, de Sauvage FJ, Kikly K, et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 1994;372:560.
19. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977;91:335.
20. Dexter TM, Moore MAS, Sheridan APC. Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J Exp Med. 1977;145:1612.
21. Van Den Heuvel R, Schoeters G, Leppens H, Vanderborght O. Stromal cells in long-term cultures of liver, spleen and bone marrow at different developmental ages have different capacities to maintain GM-CFC proliferation. Exp Hematol. 1991;19:115.
22. Yam LT, Li CY Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971;55:283.
23. Carballo E, Pirterle DM, Stumpo DJ, Sperling HT, Blackshear PJ. Phagocytic and macropinocytic activity in MARCKS-deficient macrophages and fibroblasts. Am J Physiol. 1999;277:163.
24. Agui T, Xin X, Cai Y, Tohru S, Matsumoto K. Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells. Blood. 1994;84:2531.
25. Stumpo DJ, Graff JM, Albert KA, Greengard P, Blackshear PJ. Molecular cloning, characterization and expression of a cDNA encoding the 80 to 87 kDa myristoylated alanine-rich C kinase substrate: a major cellular substrate for protein kinase C. Proc Natl Acad Sci U S A. 1989;86:4012.
26. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485.
27. Bentley, SA. The role and composition of the adherent layer in long-term bone marrow culture. In: Long Term Bone Marrow Culture: Proceedings of a Symposium Held at the Kroc Foundation. Kroc Foundation Series, Vol 18. New York, NY: Alan R. Liss, Inc; 1984.
28. Greenberger JS. Sensitivity of corticosteroid-dependent insulin-resistant lipogenesis in marrow preadipocytes of obese-diabetic (db/db) mice. Nature. 1978;275:752.
29. Thorens B, Mermod J-L, Vassalli P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell. 1987;48:671.
30. Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell. 1995;81:179.
31. Chen C-YA, Shyu A-B. Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements. Mol Cell Biol. 1994;14:8471.
32. Vogel SN, Douches SD, Kaufman EN, Neta R. Induction of colony stimulating factor in vivo by recombinant interleukin 1α and recombinant tumor necrosis factor α. J Immunol. 1987; 138:2143.
33. Koeffler HP, Gasson J, Tobler A. Transcriptional and posttranscriptional modulation of myeloid colony-stimulation factor expression by tumor necrosis factor and other agents. Mol Cell Biol. 1988;8:3432.
34. Zoja C, Wang JM, Bettoni S, et al. Interteukin-1β and tumor necrosis factor-α induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol. 1991; 138:991.
35. Derigs HG, Reifel-Miller A, Kaushansky K, Hromas RA, Boswell HS. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line. Exp Hematol. 1994;22:924.
36. Chen C-YA, Xu N, Shyu A-B. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol. 1995;15:5777.
37. Stanley E, Metcalf D, Sobieszczuk P, Gough NM, Dunn AR. The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilization of alternative promoters. EMBO J. 1985;4:2569.
38. Rubin HN, Halim MN. Stimulation of globin synthesis by 11-amino acid peptide. Biochem Mol Biol Int. 1993;31:267.
39. Baker EJ, Liggit P. Accelerated poly(A) loss and mRNA stabilization are independent effects of protein synthesis inhibition on alpha-tubulin mRNA in Chlamydomonas. Nucleic Acids Res. 1993;21:2237.
40. Rubin HN, Halim MN, Leavis PC. Apoly (A) binding protein-specific sequence motif: MRTENGKSKGFGFVC binding to mRNA poly (A) and polynucleotides and its role on mRNA translation. Biochem Mol Biol Int. 1994;33:575.
41. Beelman CA, Parker R. Differential effects of translational inhibition in cis and in trans on the decay of the unstable yeast MFA2 mRNA. J Biol Chem. 1994;269:9687.
42. Lang RA, Cuthberson RA, Dunn AR. TNFα, IL-Iα and bFGF are implicated in the complex disease of GM-CSF transgenic mice. Growth Factors. 1992;6:131.
43. Ulich TR, Shin SS, del Castillo J. Haematologic effects of TNF. Res Immunol. 1993;144:347.
44. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986;46:659.
45. Wodnar-Filipowicz A, Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc Natl Acad Sci U S A. 1990;87:777.
46. Ross HJ, Sato N, Ueyama Y, Koeffler HP. Cytokine messenger RNA stability is enhanced in tumor cells. Blood. 1991;77:1787.
47. Schuler GD, Cole MD. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell. 1988;55: 1115.
48. Antman KS, Griffin JD, Elias AA, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression N Engl J Med. 1988; 319:593.
49. Gianni A, Bregni M, Siena S. Recombinant human granulocyte macrophage colony stimulating factor reduces hematologic toxicity and widens clinical applicability of high dose cyclophosphamide treatment in breast cancer. J Clin Oncol. 1990;8:768.
50. Nemunaitis J. Use of hematopoietic growth factors in marrow transplantation. Curr Opin Oncol. 1994;6:139.
51. Vadhan-Raj S, Buescher S, Broxmeyer HE. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte macrophage colony stimulating factor. N Engl J Med. 1988;319:1628.